LINC01133 and ovarian serous cystadenocarcinoma: By using the online tool gene expression profiling interactive analysis (GEPIA) (http://gepia.cancer-pku.cn/), we found that in the cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), colon adenocarcinoma (COAD), lung squamous cell carcinoma (LUSC), ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ) and stomach adenocarcinoma (STAD), LINC01133 was significantly highly expressed in the tumor tissues compared with the normal tissues (Fig. 3A).